Harrow, Inc. (HROW)
30.12
+1.82
(+6.43%)
USD |
NASDAQ |
Nov 13, 16:00
30.09
-0.03
(-0.10%)
Pre-Market: 08:28
Harrow Price to Book Value : 38.72 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 38.72 |
| November 12, 2026 | 36.38 |
| November 11, 2026 | 37.76 |
| November 10, 2026 | 39.03 |
| November 09, 2026 | 35.31 |
| November 06, 2026 | 34.57 |
| November 05, 2026 | 33.47 |
| November 04, 2026 | 36.96 |
| November 03, 2026 | 36.69 |
| November 02, 2026 | 36.25 |
| October 30, 2026 | 36.30 |
| October 29, 2026 | 38.55 |
| October 28, 2026 | 37.78 |
| October 27, 2026 | 37.37 |
| October 26, 2026 | 37.22 |
| October 23, 2026 | 36.56 |
| October 22, 2026 | 36.19 |
| October 21, 2026 | 36.30 |
| October 20, 2026 | 36.08 |
| October 19, 2026 | 35.58 |
| October 16, 2026 | 35.07 |
| October 15, 2026 | 36.96 |
| October 14, 2026 | 35.02 |
| October 13, 2026 | 36.30 |
| October 12, 2026 | 37.42 |
| Date | Value |
|---|---|
| October 09, 2026 | 37.74 |
| October 08, 2026 | 39.23 |
| October 07, 2026 | 39.36 |
| October 06, 2026 | 39.02 |
| October 05, 2026 | 39.31 |
| October 02, 2026 | 39.18 |
| October 01, 2026 | 39.35 |
| September 30, 2026 | 39.59 |
| September 29, 2026 | 77.44 |
| September 28, 2026 | 77.93 |
| September 25, 2026 | 81.55 |
| September 24, 2026 | 81.63 |
| September 23, 2026 | 82.86 |
| September 22, 2026 | 84.96 |
| September 21, 2026 | 83.65 |
| September 18, 2026 | 81.58 |
| September 17, 2026 | 81.70 |
| September 16, 2026 | 84.36 |
| September 15, 2026 | 83.45 |
| September 14, 2026 | 84.02 |
| September 11, 2026 | 85.03 |
| September 10, 2026 | 90.21 |
| September 09, 2026 | 92.60 |
| September 08, 2026 | 93.34 |
| September 04, 2026 | 95.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.744 |
| ANI Pharmaceuticals, Inc. | 2.568 |
| Corcept Therapeutics, Inc. | 9.568 |
| Veru, Inc. | 1.256 |
| Johnson & Johnson | 8.437 |
Price to Book Value Related Metrics
| PS Ratio | 3.733 |
| PEG Ratio | -0.0956 |
| Price | 30.12 |
| Earnings Yield | -2.57% |
| Market Cap | 1.130B |
| PEGY Ratio | -0.0956 |
| Operating PE Ratio | 466.84 |